Pathophysiology of schizophrenia and the role of newer antipsychotics

Pharmacotherapy

Volumn 16, Issue 1 II, 1996, Pages

  Risch, S Craig ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; NORADRENALIN; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN; SERTINDOLE; ZIPRASIDONE;

AFFECT; ANHEDONIA; ANTISOCIAL BEHAVIOR; BRAIN METABOLISM; CONFERENCE PAPER; DELUSION; DOPAMINERGIC SYSTEM; DRUG EFFICACY; HALLUCINATION; HUMAN; NEUROTRANSMISSION; POSITRON EMISSION TOMOGRAPHY; SCHIZOPHRENIA; TARDIVE DYSKINESIA; THOUGHT DISORDER;

ADRENERGIC ALPHA-AGONISTS; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN CHEMISTRY; CHLORPROMAZINE; DOPAMINE ANTAGONISTS; HALOPERIDOL; HUMANS; NOREPINEPHRINE; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS;

EID: 0030066587     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Andreasen NC Brain imaging: application in psychiatry. Science 1988,239:1381-8
2. Weinberger DR. Neurodevelopmental perspectives on schizophrenia In Bloom FE, Kupfer OJ, eds. Psychopharmacology the fourth generation of progress. New York: Raven Press, 1995:1171-3.
3. Buchbaum MS, Potkin SG, Marshall JF, et al. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia Neuropsychopharmacology 1993;6-155-63.
4. Andreasen NC, Arndt S, Swayze V, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994,266:294-8.
5. Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 1992;149:890-7.
6. Martin MB, Owen CM, Morihisa JM. An overview of neurotransmitters and neuroceptors. In Hales RE, Yudofsky SC, eds Textbook of neuropsychiatry. Washington, DC: American Psychiatric Press, 1987;4.55-85.
7. Roth BL, Meltzer HY. The role of serotonin in schizophrenia. In: Bloom FE, Kupfer OJ, eds. Psychopharmacology: the fourth generation of progress New York: Raven Press, 1995-1215-27
8. Joyce JN, Shane A, Lexow N, et al Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 1993;8-315-36
9. Risch SC, Nemeroff CB. Neurochemical alterations of serotonergic neuronal systems depression. J Clin Psychiatry 1992;53 3-7
10. Risch SC, Lewine RRJ. Low cerebrospinal fluid homovanillic acid-5-hydroxyindoleacetic acid ratio predicts clozapine efficiency: a replication [letter]. Arch Gen Psychiatry 1993;50:670.
11. Risch SC, Lewine RRJ. CSF HVA:5H1AA ratio increases accompanying clozapine efficacy [letter]. Arch Gen Psychiatry 1995;52:244.
12. Pickar D, Litman RE, Hong WW, et al. Clinical response to clozapine in patients with schizophrenia [letter]. Arch Gen Psychiatry 1994;51.159.
13. Owens MJ, Risch SC Atypical antipsychotics In. Schatzberg A, Nemeroff CB, eds. Textbook of psychopharmacology. Washington, DC American Psychiatric Press, 1995:263-80.